|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.664
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.162
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.141
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.132
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.123
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.123
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.121
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.119
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.109
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.104
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.104
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.100
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.094
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.088
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.088
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.083
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.082
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.080
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.078
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.077
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.076
|
|
|
|
neutrophil mediated killing of gram positive bacterium
|
GO:0070946 |
2 |
0.076
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.075
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.073
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.073
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.072
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.072
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.071
|
|
|
|
granzyme mediated apoptotic signaling pathway
|
GO:0008626 |
1 |
0.070
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.069
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.069
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.066
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.065
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.065
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.064
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.063
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.062
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.061
|
|
|
|
serotonin receptor signaling pathway
|
GO:0007210 |
8 |
0.058
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.058
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.057
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.056
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.056
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.056
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.055
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.055
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.055
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.052
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.052
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.052
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.051
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.049
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.048
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.048
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.047
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.046
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.046
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.046
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.045
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.044
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.043
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.042
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.042
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.042
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.042
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.041
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.041
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.041
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.041
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.041
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.041
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.040
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.040
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.040
|
|
|
|
vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure
|
GO:0002025 |
3 |
0.039
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.039
|
|
|
|
positive regulation of immunological synapse formation
|
GO:2000522 |
1 |
0.039
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.038
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.038
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.037
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.037
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.037
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.037
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.036
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.036
|
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.036
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.036
|
|
|
|
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
|
GO:0003072 |
5 |
0.035
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.035
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.035
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.034
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.034
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.033
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.033
|
|
|
|
regulation of dendritic cell chemotaxis
|
GO:2000508 |
1 |
0.033
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.033
|
|
|
|
disruption of cells of other organism
|
GO:0044364 |
13 |
0.033
|
|
|
|
positive regulation of steroid hormone secretion
|
GO:2000833 |
2 |
0.033
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.033
|
|
|
|
dibenzo p dioxin metabolic process
|
GO:0018894 |
1 |
0.033
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.033
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.032
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.032
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.031
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.031
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.031
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.031
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.031
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.031
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.031
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.031
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.030
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.030
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.029
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.029
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.029
|
|
|
|
histamine induced gastric acid secretion
|
GO:0001697 |
1 |
0.029
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.028
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.028
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.028
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.028
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.028
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.028
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.028
|
|
|
|
negative regulation of adenylate cyclase activity
|
GO:0007194 |
1 |
0.028
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.027
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.027
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.027
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.027
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.027
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.026
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.026
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.026
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.026
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.026
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.026
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.025
|
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.025
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.025
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.025
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.025
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.025
|
|
|
|
activation of membrane attack complex
|
GO:0001905 |
4 |
0.025
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.025
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.025
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.025
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.024
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.024
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.024
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.024
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.024
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.024
|
|
|
|
t helper 17 cell chemotaxis
|
GO:0035705 |
1 |
0.024
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.023
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.023
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.023
|
|
|
|
cellular response to temperature stimulus
|
GO:0071502 |
2 |
0.023
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.023
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.023
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.023
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.023
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.023
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.023
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.022
|
|
|
|
hematopoietic stem cell migration
|
GO:0035701 |
1 |
0.022
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.022
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.022
|
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.022
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.022
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.022
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.022
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.022
|
|
|
|
immune complex clearance
|
GO:0002434 |
2 |
0.021
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.021
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.021
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.021
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.021
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.021
|
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.021
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.021
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.020
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.020
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.020
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.020
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.020
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.020
|
|
|
|
phospholipase c activating serotonin receptor signaling pathway
|
GO:0007208 |
1 |
0.020
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.020
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.020
|
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.020
|
|
|
|
positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation
|
GO:2000526 |
1 |
0.020
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.020
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.020
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.020
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.019
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.019
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.019
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.019
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.019
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.019
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.019
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.019
|
|
|
|
positive regulation of t cell costimulation
|
GO:2000525 |
2 |
0.019
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.019
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.019
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.019
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.019
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.019
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.018
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.018
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.018
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.018
|
|
|
|
interleukin 12 secretion
|
GO:0072610 |
3 |
0.018
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.018
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.018
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.018
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.018
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.018
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.018
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.018
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.018
|
|
|
|
gastrin induced gastric acid secretion
|
GO:0001698 |
1 |
0.017
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.017
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.017
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.017
|
|
|
|
t cell extravasation
|
GO:0072683 |
4 |
0.017
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.017
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.017
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.017
|
|
|
|
regulation of hematopoietic stem cell migration
|
GO:2000471 |
1 |
0.017
|
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.017
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.017
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.016
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.016
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.016
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.016
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.016
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.016
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.016
|
|
|
|
regulation of type 2 immune response
|
GO:0002828 |
18 |
0.016
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.016
|
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.016
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.016
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.016
|
|
|
|
positive regulation of endothelial cell proliferation
|
GO:0001938 |
17 |
0.016
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.016
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.016
|
|
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.016
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.016
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.016
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.016
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.016
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.016
|
|
|
|
negative regulation of t cell cytokine production
|
GO:0002725 |
1 |
0.016
|
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.016
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.015
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.015
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.015
|
|
|
|
positive regulation of immune complex clearance by monocytes and macrophages
|
GO:0090265 |
2 |
0.015
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.015
|
|
|
|
interleukin 13 secretion
|
GO:0072611 |
2 |
0.015
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.015
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.015
|
|
|
|
negative regulation of interleukin 5 production
|
GO:0032714 |
4 |
0.015
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.015
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.015
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.015
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.015
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.015
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.015
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.015
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.015
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.014
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.014
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.014
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.014
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.014
|
|
|
|
catecholamine uptake
|
GO:0090493 |
4 |
0.014
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.014
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.014
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.014
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.014
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.014
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.014
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.014
|
|
|
|
cellular response to antibiotic
|
GO:0071236 |
4 |
0.014
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.014
|
|
|
|
t helper 2 cell cytokine production
|
GO:0035745 |
4 |
0.014
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.014
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.014
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.014
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.014
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.014
|
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.014
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.014
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.014
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.014
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.014
|
|
|
|
negative regulation of interleukin 13 secretion
|
GO:2000666 |
1 |
0.013
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.013
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.013
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.013
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.013
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.013
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.013
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.013
|
|
|
|
nucleosome positioning
|
GO:0016584 |
4 |
0.013
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.013
|
|
|
|
positive regulation of phospholipase c activity
|
GO:0010863 |
2 |
0.013
|
|
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.013
|
|
|
|
negative regulation of type 2 immune response
|
GO:0002829 |
8 |
0.013
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.013
|
|
|
|
sperm ejaculation
|
GO:0042713 |
1 |
0.013
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.013
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.013
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.013
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.013
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.013
|
|
|
|
regulation of catecholamine uptake involved in synaptic transmission
|
GO:0051940 |
2 |
0.013
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.013
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.013
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.013
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.012
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.012
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.012
|
|
|
|
porphyrin containing compound metabolic process
|
GO:0006778 |
22 |
0.012
|
|
|
|
cellular response to ammonium ion
|
GO:0071242 |
2 |
0.012
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.012
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.012
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.012
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.012
|
|
|
|
negative regulation of cyclase activity
|
GO:0031280 |
1 |
0.012
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.012
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.012
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.012
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.012
|
|
|
|
chloride transmembrane transport
|
GO:1902476 |
24 |
0.012
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.012
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.012
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.012
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.012
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.012
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.012
|
|
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
26 |
0.012
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.012
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.012
|
|
|
|
synaptic transmission glycinergic
|
GO:0060012 |
2 |
0.012
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
23 |
0.012
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.012
|
|
|
|
proprioception
|
GO:0019230 |
4 |
0.012
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.012
|
|
|
|
tetrapyrrole metabolic process
|
GO:0033013 |
22 |
0.012
|
|
|
|
response to iron ion
|
GO:0010039 |
4 |
0.012
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.012
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.012
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.012
|
|
|
|
negative regulation of cyclic nucleotide metabolic process
|
GO:0030800 |
5 |
0.012
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.012
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.012
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.012
|
|
|
|
negative regulation of leukocyte mediated immunity
|
GO:0002704 |
29 |
0.012
|
|
|
|
regulation of cell killing
|
GO:0031341 |
40 |
0.012
|
|
|
|
killing of cells in other organism involved in symbiotic interaction
|
GO:0051883 |
13 |
0.011
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.011
|
|
|
|
negative regulation of purine nucleotide metabolic process
|
GO:1900543 |
16 |
0.011
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.011
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.011
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.011
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.011
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.011
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.011
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.011
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.011
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.011
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.011
|
|
|
|
linoleic acid metabolic process
|
GO:0043651 |
6 |
0.011
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.011
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.011
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.011
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.011
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.011
|
|
|
|
exogenous drug catabolic process
|
GO:0042738 |
1 |
0.011
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.011
|
|
|
|
neutrophil mediated immunity
|
GO:0002446 |
19 |
0.011
|
|
|
|
positive regulation of monocyte extravasation
|
GO:2000439 |
1 |
0.011
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.011
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.011
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.011
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.011
|
|
|
|
sensitization
|
GO:0046960 |
2 |
0.011
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.011
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.011
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.011
|
|
|
|
positive regulation of gliogenesis
|
GO:0014015 |
27 |
0.011
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.010
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.010
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.010
|
|
|
|
response to histamine
|
GO:0034776 |
1 |
0.010
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.010
|
|
|
|
eosinophil activation
|
GO:0043307 |
1 |
0.010
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.010
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.010
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.010
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.010
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.010
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.010
|
|
|
|
negative regulation of lyase activity
|
GO:0051350 |
1 |
0.010
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.010
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.010
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.010
|
|
|
|
interaction with symbiont
|
GO:0051702 |
14 |
0.010
|
|
|
|
response to mineralocorticoid
|
GO:0051385 |
1 |
0.010
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.010
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.010
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.010
|
|
|
|
negative regulation of leukocyte apoptotic process
|
GO:2000107 |
31 |
0.010
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.010
|
|
